Related Experiment Video
Updated: Jul 19, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated
Weihua Zhao1, Wenjie Xie, Qin Xiao
1Department of Neurology, Methodist Neurological Institute, The Methodist Hospital, Houston, Texas 77030, USA.
Abstract:
Microglia-mediated cytotoxicity has been implicated in models of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease, but few studies have documented how neuroprotective signals might mitigate such cytotoxicity. To explore the neuroprotective mechanism of anti-inflammatory cytokines, we applied interleukin-4 (IL-4) to primary microglial cultures activated by lipopolysaccharide as well as to activated microglia cocultured with primary motoneurons. lipopolysaccharide increased nitric oxide and superoxide (O(2) (.-)) and decreased insulin-like growth factor-1 (IGF-1) release from microglial cultures, and induced motoneuron injury in microglia-motoneuron cocultures. However, lipopolysaccharide had minimal effects on isolated motoneuron cultures. IL-4 interaction with microglial IL-4 receptors suppressed and nitric oxide release, and lessened lipopolysaccharide-induced microglia-mediated motoneuron injury. The extent of nitric oxide suppression correlated directly with the extent of motoneuron survival. Although IL-4 enhanced release of free IGF-1 from microglia in the absence of lipopolysaccharide, it did not enhance free IGF-1 release in the presence of lipopolysaccharide. These data suggest that IL-4 may provide a significant immunomodulatory signal which can protect against microglia-mediated neurotoxicity by suppressing the production and release of free radicals.
Insights
Interleukin-4 (IL-4) protects neurons from microglia-mediated injury by reducing harmful free radicals. This finding offers a potential therapeutic strategy for neurodegenerative diseases involving microglial activation.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia-mediated cytotoxicity is a key factor in neurodegenerative diseases like ALS, Parkinson's, and Alzheimer's.
- Neuroprotective signals that counteract microglial activation are not well understood.
Purpose of the Study:
- To investigate the neuroprotective mechanisms of anti-inflammatory cytokines, specifically interleukin-4 (IL-4).
- To determine IL-4's effect on lipopolysaccharide (LPS)-activated microglia and their subsequent impact on motoneurons.
Main Methods:
- Primary microglial cultures and microglia-motoneuron cocultures were treated with lipopolysaccharide (LPS) and/or interleukin-4 (IL-4).
- Nitric oxide, superoxide, and insulin-like growth factor-1 (IGF-1) release were measured.
- Motoneuron injury was assessed in coculture models.
Main Results:
- LPS-activated microglia released nitric oxide and superoxide, causing motoneuron injury.
- IL-4 treatment suppressed nitric oxide release from activated microglia.
- IL-4 significantly reduced LPS-induced microglia-mediated motoneuron injury, with suppression extent correlating to motoneuron survival.
Conclusions:
- Interleukin-4 (IL-4) demonstrates significant neuroprotective effects against microglia-mediated toxicity.
- IL-4 acts as an immunomodulatory signal, protecting neurons by suppressing free radical production from activated microglia.
- Targeting IL-4 signaling may offer a therapeutic avenue for neurodegenerative conditions characterized by microglial activation.
